The Potential Cardioprotective Effect of Addition of Atorvastatin in Breast Cancer Patients
NCT07668076
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
44
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Doxorubicin Induced Cardiomyopathy
Interventions
DRUG:
Atorvastatin
Sponsor
Damanhour University